" Hello doctor, My sister is 38 years old and was recently diagnosed with early endometrial cancer after a biopsy. She has not had children yet and is hoping to conceive in the future. The doctor mentioned the possibility of hormonal treatment using Megace instead of immediate surgery. Is this fertility-preserving approach safe or risky? How often does cancer respond to hormone therapy like this? Also, if the treatment works for now, will she still need a hysterectomy later after pregnancy? We are trying to understand realistic options before making a decision. Kindly advise.

" Hello, Welcome to icliniq.com. I understand your concern. Yes, a fertility-preserving approach can be considered in some women with early endometrial cancer , but it is not suitable for everyone. It is usually offered only in carefully selected cases and requires close monitoring. Hormonal therapy is usually considered only if the tumor is low-grade (Grade 1) or the cancer is limited to the endometrium (inner lining of the uterus) with no deeper invasion on magnetic resonance imaging (MRI). There is no spread outside the uterus, and the patient is willing to undergo strict and regular follow-up. The treatment commonly involves Megestrol acetate, which is a progesterone-based medicine. In some cases, it may also be combined with a progesterone-releasing intrauterine device. In carefully selected patients: Around 60 to 80 percent achieve a complete response (no cancer seen on biopsy). Around 30 to 40 percent may have recurrence later. Because of this, close monitoring is very important, usually with an endometrial biopsy every three to six months. If the cancer responds well, pregnancy is usually advised soon after remission, and fertility treatments may be considered if required. Even if the treatment works and pregnancy is achieved, hysterectomy (removal of the uterus) is generally recommended after completing childbearing to reduce the risk of recurrence. In simple terms, this approach can help preserve fertility for some time, but it is usually a temporary plan, and surgery is often advised later for long-term safety. I hope you are satisfied with my answer. For further queries, you can consult me at iCliniq. Thank you.

Can women conceive with early endometrial cancer treatment?

This Premium Q&A, reviewed and published, features a real conversation between an iCliniq user and a physician.

Patient's Query

Hello doctor,

My sister is 38 years old and was recently diagnosed with early endometrial cancer after a biopsy. She has not had children yet and is hoping to conceive in the future.

The doctor mentioned the possibility of hormonal treatment using Megace instead of immediate surgery.

Is this fertility-preserving approach safe or risky?
How often does cancer respond to hormone therapy like this?
Also, if the treatment works for now, will she still need a hysterectomy later after pregnancy?

We are trying to understand realistic options before making a decision.

Kindly advise.

Answered by Dr. Neha Nigam

Hello,

Welcome to icliniq.com.

I understand your concern.

Yes, a fertility-preserving approach can be considered in some women with early endometrial cancer, but it is not suitable for everyone. It is usually offered only in carefully selected cases and requires close monitoring.

Hormonal therapy is usually considered only if the tumor is low-grade (Grade 1) or the cancer is limited to the endometrium (inner lining of the uterus) with no deeper invasion on magnetic resonance imaging (MRI). There is no spread outside the uterus, and the patient is willing to undergo strict and regular follow-up.

The treatment commonly involves Megestrol acetate, which is a progesterone-based medicine. In some cases, it may also be combined with a progesterone-releasing intrauterine device.

In carefully selected patients:

Around 60 to 80 percent achieve a complete response (no cancer seen on biopsy).
Around 30 to 40 percent may have recurrence later.

Because of this, close monitoring is very important, usually with an endometrial biopsy every three to six months. If the cancer responds well, pregnancy is usually advised soon after remission, and fertility treatments may be considered if required.

Even if the treatment works and pregnancy is achieved, hysterectomy (removal of the uterus) is generally recommended after completing childbearing to reduce the risk of recurrence. In simple terms, this approach can help preserve fertility for some time, but it is usually a temporary plan, and surgery is often advised later for long-term safety.

I hope you are satisfied with my answer. For further queries, you can consult me at iCliniq.

Thank you.

Was this conversation helpful?

Answered by Dr. Neha Nigam

Medically reviewed by iCliniq medical review team

March 20, 2026

Same symptoms don't mean you have the same problem. Consult a doctor now!

1,200Visits prepared today

4.8/5User rating

~60 secAverage completion

Early Endometrial Cancer Fertility Companion

How it works

Early endometrial cancer is cancer of the lining of the uterus that has not yet grown into the uterine wall or spread beyond it. For some women who hope to have a child, a fertility-sparing pathway may be considered alongside the standard surgical option. Your healthcare provider decides what is appropriate for your situation.

1🩺

What
is it

2🔬

Who may
qualify

3📋

What the
workup is

4🌱

Treatment
options

5📅

Why followup
matters

6👶

After
remission

Why fertility-sparing care is even on the table

Most endometrial cancers are caught early because of unusual bleeding. When the cancer is small, low grade, and has not grown into the uterine wall, your gynecologist may discuss a fertility-sparing pathway alongside the standard surgery. The right fit depends on the biopsy report, imaging, and a conversation with your healthcare provider about your goals.

Dr. Neha Nigam

Obstetrics and Gynecology

Consult this doctor